» Articles » PMID: 37173674

Plasmid-mediated Quinolone Resistance Genes Detected in Ciprofloxacin Non-susceptible Escherichia Coli and Klebsiella Isolated from Children Under Five Years at Hospital Discharge, Kenya

Abstract

Background: The increasing spread of fluoroquinolone resistant enteric bacteria is a global public health concern. Children recently discharged from the hospital are at high risk of carriage of antimicrobial resistance (AMR) due to frequent exposure to antimicrobials during inpatient stays. This study aimed to determine the prevalence, correlates of ciprofloxacin (CIP) non-susceptibility, and distribution of plasmid-mediated quinolone resistance (PMQR) genes in Escherichia coli (E. coli) and Klebsiella spp isolated from children under five years being discharged from two Kenyan Hospitals.

Methods: E. coli and Klebsiella spp were isolated from fecal samples from children discharged from hospital and subjected to antimicrobial susceptibility testing (AST) by disc diffusion and E-test. CIP non-susceptible isolates were screened for seven PMQR genes using multiplex polymerase chain reaction (PCR). Poisson regression was used to determine the association between the carriage of CIP non-susceptible isolates and patient characteristics.

Results: Of the 280 CIP non-susceptible isolates: 188 E. coli and 92 Klebsiella spp isolates identified among 266 discharged children, 195 (68%) were CIP-non-susceptible with minimum inhibitory concentrations (MICs) of ≥ 1 µg/mL. Among these 195 isolates, 130 (67%) had high-level CIP MIC =  ≥ 32 µg/mL). Over 80% of the isolates had at least one PMQR gene identified: aac(6')lb-cr (60%), qnrB (24%), oqxAB (22%), qnrS (16%), and qepA (6%), however, qnrA was not identified in any isolates tested. Co-carriage of qnrB with acc(6')-lb-cr was the most predominant accounting for 20% of all the isolates. Ceftriaxone use during hospital admission and the presence of extended spectrum beta-lactamase (ESBL) production were significantly associated with the carriage of CIP non-susceptible E. coli and Klebsiella spp.

Conclusion: CIP non-susceptibility is common among E. coli and Klebsiella spp isolated from hospital discharged children in Kenya. Carriage and co-carriage of PMQR, including the newly identified qepA gene, were frequently observed. These findings suggest that children leaving the hospital may serve as an important reservoir for transmission of resistant E. coli and Klebsiella spp to the community. Enhanced surveillance for AMR determinants is critical to inform interventions to control antimicrobial-resistant bacteria.

Citing Articles

Study of plasmid mediated quinolone resistance genes among Escherichia coli and Klebsiella pneumoniae isolated from pediatric patients with sepsis.

Elsayed A, Fahmy E, Alsayed M, Ahmed M, Zaki M, Mofreh Mohamed M Sci Rep. 2024; 14(1):11849.

PMID: 38783019 PMC: 11116374. DOI: 10.1038/s41598-024-61357-z.


Phenotypic and molecular characterization of β-lactamase-producing Klebsiella species among children discharged from hospital in Western Kenya.

Rwigi D, Nyerere A, Diakhate M, Kariuki K, Tickell K, Mutuma T BMC Microbiol. 2024; 24(1):135.

PMID: 38654237 PMC: 11040804. DOI: 10.1186/s12866-024-03284-7.


The Abundance of Plasmid-Mediated Quinolone Resistance Genes in Strains Isolated from Clinical Specimens in Kermanshah, Iran.

Afsharian M, Asadi S, Danesh C, Sedighi R, Karimi K, Miladi N Can J Infect Dis Med Microbiol. 2024; 2024:8849097.

PMID: 38623587 PMC: 11018368. DOI: 10.1155/2024/8849097.


Antimicrobial resistance in E. Coli of animal origin and discovery of a novel ICE mobile element in Northeast China.

Zhu D, Ding Q, Li P, Wang Y, Li Y, Yu Li X BMC Vet Res. 2023; 19(1):255.

PMID: 38053138 PMC: 10696688. DOI: 10.1186/s12917-023-03828-5.


Characterization of Beta-Lactamase and Fluoroquinolone Resistance Determinants in , and Isolates from a Tertiary Hospital in Yola, Nigeria.

Kawa D, Tickler I, Tenover F, Shettima S Trop Med Infect Dis. 2023; 8(11).

PMID: 37999619 PMC: 10675496. DOI: 10.3390/tropicalmed8110500.

References
1.
Pilmis B, Monnier A, Zahar J . Gut Microbiota, Antibiotic Therapy and Antimicrobial Resistance: A Narrative Review. Microorganisms. 2020; 8(2). PMC: 7074698. DOI: 10.3390/microorganisms8020269. View

2.
Robicsek A, Strahilevitz J, Jacoby G, Macielag M, Abbanat D, Park C . Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase. Nat Med. 2005; 12(1):83-8. DOI: 10.1038/nm1347. View

3.
Park C, Robicsek A, Jacoby G, Sahm D, Hooper D . Prevalence in the United States of aac(6')-Ib-cr encoding a ciprofloxacin-modifying enzyme. Antimicrob Agents Chemother. 2006; 50(11):3953-5. PMC: 1635235. DOI: 10.1128/AAC.00915-06. View

4.
Taitt C, Leski T, Erwin D, Odundo E, Kipkemoi N, Ndonye J . Antimicrobial resistance of Klebsiella pneumoniae stool isolates circulating in Kenya. PLoS One. 2017; 12(6):e0178880. PMC: 5456380. DOI: 10.1371/journal.pone.0178880. View

5.
Abd El-Aziz N, Gharib A . Coexistence of plasmid-mediated quinolone resistance determinants and AmpC-Beta-Lactamases in Escherichia coli strains in Egypt. Cell Mol Biol (Noisy-le-grand). 2015; 61(5):29-35. View